S, V., K, H., MA, H., & S, F. (2024). Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. Applied health economics and health policy, 22(5), 629. https://doi.org/10.1007/s40258-024-00888-y
Chicago Style (17th ed.) CitationS, Vogler, Habimana K, Haasis MA, and Fischer S. "Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally." Applied Health Economics and Health Policy 22, no. 5 (2024): 629. https://doi.org/10.1007/s40258-024-00888-y.
MLA (9th ed.) CitationS, Vogler, et al. "Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally." Applied Health Economics and Health Policy, vol. 22, no. 5, 2024, p. 629, https://doi.org/10.1007/s40258-024-00888-y.